Related Experiment Video

Updated: May 19, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
04:37

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development

Published on: June 16, 2023

Heart for bonding: a new protocol of care for hypoplastic left heart syndrome

Mary E Parker1, Wanda T Bradshaw, Hope R Smith

  • 1Neonatal Intensive Care Nursery, Duke University Medical Center, Durham, NC 27710, USA. mep71964@mindspring.com

Neonatal Network : NN
|August 22, 2012
PubMed

Insights

Caring for infants with hypoplastic left heart syndrome (HLHS) presents unique challenges for families. This case study explores how one family

Area of Science:

  • Neonatal Intensive Care
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect requiring complex perinatal and postnatal care.
  • Families face significant emotional and practical challenges when an infant is diagnosed with HLHS.
  • The desire for a 'normal' birth experience can conflict with the realities of caring for an infant with HLHS.

Observation:

  • A case study details the experience of a family with an infant diagnosed with HLHS.
  • The family's proactive desire to normalize the birth experience was a key factor.
  • This desire prompted a re-evaluation of care philosophies within the neonatal intensive care unit.

Findings:

  • The family's perspective challenged existing practices in HLHS care.
  • A shift in philosophy was initiated, focusing on family-centered care.
  • Adaptations in neonatal intensive care unit (NICU) practices were implemented.

Implications:

  • This case highlights the importance of family-centered approaches in managing HLHS.
  • It suggests that family desires can drive positive changes in clinical practice.
  • Improved integration of family needs into NICU protocols for congenital heart defects is recommended.

More Related Videos

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...